DJIA 17,751.39 121.12 0.69%
NASDAQ 5,111.73 22.53 0.44%
S&P 500 2,108.57 15.32 0.73%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

171.47 -1.27 (-0.74%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMGN $171.47 -0.74%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $172.92
Previous Close $172.74
Daily Range $169.12 - $173.68
52-Week Range $122.25 - $174.80
Market Cap $130.4B
P/E Ratio 23.31
Dividend (Yield) $3.16 (1.8%)
Ex-Dividend Date
Dividend Pay Date
05/12/15
06/05/15
Volume 5,110,786
Average Daily Volume 3,219,009
Current FY EPS $9.61

Sector

Healthcare

Industry

Drug Makers

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary Rss Feed

3 Questions to Ask Ahead of Amgen's Second-Quarter Earnings Release

The next big catalyst is right around the corner for Amgen. Find out what important questions you should be asking as Amgen readies to report its second-quarter earnings results on July 30.

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst Blog

3 Stocks Pushing The Drugs Industry Lower

Today's Market: Names Riding Momentum To All-Time Highs, Earnings To Focus On

Will Amgen (AMGN) Keep the Earnings Streak Alive in 2Q? - Analyst Blog

Merck Tops on Q2 Earnings & Revenues, Revises Outlook - Analyst Blog

Is More M&A On The Way For Large-Cap Biotechs?

NantKwest Inc.: Our IPO Pick Of The Week

Nasdaq 100 Movers: BIDU, AMGN

Trade-Ideas: Amgen (AMGN) Is Today's Strong On High Relative Volume Stock

Benzinga's M&A Chatter for Monday July 27, 2015

See More AMGN News...

AMGN's Top Competitors

AMGN $171.47 (-0.74%)
Current stock: AMGN
GILD $115.71 (2.33%)
Current stock: GILD
CELG $132.14 (-2.42%)
Current stock: CELG
$0.00 (0.00%)
Current stock: